Astra Space Inc - Ordinary Shares (ASTR) 10-Q 15 May 23 2023 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2023	May 08, 2023
Document Information [Line Items]
Document Quarterly Report	true
Document Transition Report	false
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-39426
Entity Central Index Key	0001814329
Entity Registrant Name	ASTRA SPACE, INC.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1900 Skyhawk Street
Entity Address, City or Town	Alameda
Entity Address, State or Province	CA
Entity Tax Identification Number	85-1270303
Entity Address, Postal Zip Code	94501
City Area Code	866
Local Phone Number	278-7217
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	ASTR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Document Fiscal Period Focus	Q1
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		215,286,444
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		55,539,188

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 16,805	$ 33,644
Marketable securities	45,944	69,173
Trade accounts receivable	6,798	5,327
Inventories	6,925	6,588
Prepaid and other current assets	12,437	11,050
Total current assets	88,909	125,782
Non-current assets:
Property, plant and equipment, net	26,432	24,271
Right-of-use asset	11,903	12,813
Intangible assets, net	9,565	10,132
Other non-current assets	1,872	1,701
Total assets	138,681	174,699
Current liabilities:
Accounts payable	6,901	1,799
Operating lease obligation, current portion	3,779	3,800
Contingent consideration	31,135	33,900
Accrued expenses and other current liabilities	42,761	42,043
Total current liabilities	84,576	81,542
Non-current liabilities:
Operating lease obligation, net of current portion	8,254	9,051
Other non-current liabilities	2,596	1,796
Total liabilities	95,426	92,389
Commitments and Contingencies (Note 7)
STOCKHOLDERS' EQUITY
Additional paid in capital	1,907,982	1,902,213
Accumulated other comprehensive loss	(41)	(110)
Accumulated deficit	(1,864,714)	(1,819,821)
Total stockholders' equity	43,255	82,310
Total liabilities and stockholders' equity	138,681	174,699
Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Founders convertible preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of March 31, 2023 and December 31, 2022	0	0
Common Class A [Member]
STOCKHOLDERS' EQUITY
Common stock Value	22	22
Common Class B [Member]
STOCKHOLDERS' EQUITY
Common stock Value	$ 6	$ 6

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Preferred stock, shares outstanding	0
Common stock, shares authorized	466,000,000
Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Class A [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	215,286,444	213,697,468
Common stock, shares outstanding	215,286,444	213,697,468
Common Class B [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	65,000,000	65,000,000
Common stock, shares issued	55,539,188	55,539,188
Common stock, shares outstanding	55,539,188	55,539,188

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue	$ 0	$ 3,911
Cost of Revenue	0	11,014
Gross loss	0	(7,103)
Operating expenses:
Research and development	31,082	37,927
Sales and marketing	2,484	4,764
General and administrative	15,682	20,986
(Gain) Loss on change in fair value of contingent consideration	(2,765)	15,500
Total operating expenses	46,483	79,177
Operating loss	(46,483)	(86,280)
Interest income	1,330	174
Other income	260	393
Loss before taxes	(44,893)	(85,713)
Income tax provision	0	0
Net loss	(44,893)	(85,713)
Launch Services [Member]
Revenue	0	3,911
Cost of Revenue	0	11,014
Gross loss	0	(7,103)
Space Products [Member]
Revenue	0	0
Cost of Revenue	0	0
Gross loss	$ 0	$ 0
Common Class A [Member]
Earnings Per Share [Abstract]
Earnings Per Share Basic	$ (0.17)	$ (0.33)
Earnings Per Share Diluted	$ (0.17)	$ (0.33)
Dilutive weighted average common shares outstanding	214,706,779	208,112,630
Basic weighted average common shares outstanding	214,706,779	208,112,630
Common Class B [Member]
Earnings Per Share [Abstract]
Earnings Per Share Basic	$ (0.17)	$ (0.33)
Earnings Per Share Diluted	$ (0.17)	$ (0.33)
Dilutive weighted average common shares outstanding	55,539,188	55,539,188
Basic weighted average common shares outstanding	55,539,188	55,539,188

Condensed Consolidated Statemen

Condensed Consolidated Statement of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Other Comprehensive Income [Abstract]
Net loss	$ (44,893)	$ (85,713)
Other comprehensive loss
Unrealized gain (loss) on available-for-sale marketable securities	69	(155)
Total comprehensive loss	$ (44,824)	$ (85,868)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Temporary Equity and Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock [Member] Founders Preferred Stock [Member]	Common Stock [Member] Common Class A [Member]	Common Stock [Member] Common Class B [Member]	Additional Paid in Capital [Member]	Accumulated Other Comprehensive loss [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2021	$ 436,520	$ 0	$ 22	$ 6	$ 1,844,875	$ 0	$ (1,408,383)
Beginning Balance (in shares) at Dec. 31, 2021		0	207,451,107	55,539,188
Stock-based compensation	17,041				17,041
Issuance Of Common Stock Under Equity Plans, Shares			1,159,383
Issuance Of Common Stock Under Equity Plans	793				793
Unrealized loss on available-for-sale marketable securities	(155)					(155)
Net loss	(85,713)						(85,713)
Ending Balance at Mar. 31, 2022	368,486	$ 0	$ 22	$ 6	1,862,709	(155)	(1,494,096)
Ending Balance (in shares) at Mar. 31, 2022		0	208,610,490	55,539,188
Beginning Balance at Dec. 31, 2022	82,310	$ 0	$ 22	$ 6	1,902,213	(110)	(1,819,821)
Beginning Balance (in shares) at Dec. 31, 2022		0	213,697,468	55,539,188
Stock-based compensation	5,328				5,328
Issuance Of Common Stock Under Equity Plans, Shares			1,588,976
Issuance Of Common Stock Under Equity Plans	441				441
Unrealized loss on available-for-sale marketable securities	69					69
Net loss	(44,893)						(44,893)
Ending Balance at Mar. 31, 2023	$ 43,255	$ 0	$ 22	$ 6	$ 1,907,982	$ (41)	$ (1,864,714)
Ending Balance (in shares) at Mar. 31, 2023		0	215,286,444	55,539,188

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (44,893)	$ (85,713)
Adjustments to reconcile net loss to cash flows used in operating activities
Stock-based compensation	5,328	17,041
Depreciation	778	1,960
Amortization of intangible assets	567	815
Inventory write-downs	0	5,500
Non-cash lease expense	910	352
Loss (Gain) on change in fair value of contingent consideration	(2,765)	15,500
Accretion (amortization) of marketable securities purchased at a premium (discount)	(452)	67
Trade accounts receivable	(1,471)	1,383
Inventories	(337)	(6,526)
Prepaid and other current assets	(1,387)	1,005
Other non-current assets	(171)	97
Accounts payable	7,043	125
Lease liabilities	(818)	(306)
Accrued expenses and other current liabilities	868	(72)
Other non-current liabilities	801	498
Net cash used in operating activities	(35,999)	(48,274)
Cash flows from investing activities:
Acquisition of trademark	0	(850)
Purchases of marketable securities	0	(93,891)
Proceeds from maturities of marketable securities	23,750	0
Purchases of property, plant and equipment	(5,031)	(20,942)
Net cash provided by (used in) investing activities	18,719	(115,683)
Cash flows from financing activities:
Proceeds from issuance of common stock under equity plans	434	79
Proceeds from Employee Stock Purchase Plans	7	392
Net cash provided by financing activities	441	471
Net decrease in cash and cash equivalents	(16,839)	(163,486)
Cash and cash equivalents at beginning of period	33,644	325,007
Cash and cash equivalents at end of period	16,805	161,521
Non-cash investing and financing activities:
Assets acquired included in accounts payable, accrued expenses and other current liabilities	$ 1,262	$ 3,252

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Description of Business, Basis of Presentation and Significant Accounting Policies	Note 1 — Description of Business, Basis of Presentation and Significant Accounting Policies Description of Business Astra Space, Inc. (the "Company") designs, tests, manufactures and operates the next generation of launch services and space products and services that it expects to enable a new generation of global communications, earth observation, precision weather monitoring, navigation, and surveillance capabilities. The Company's mission is to Improve Life on Earth from Space ® through greater connectivity and more regular observation and to enable a wave of innovation in low Earth orbit by expanding its space platform offerings. Holicity Inc. (“Holicity”) was originally incorporated in Delaware and was established as a special purpose acquisition company, which completed its initial public offering in August 2020. On June 30, 2021 (the “Closing Date”), Holicity consummated a business combination (the “Business Combination”) pursuant to the Business Combination Agreement dated as of February 2, 2021 (the “BCA”), by and among Holicity, Holicity Merger Sub Inc., a wholly owned subsidiary of Holicity (“Merger Sub”), and Astra Space Operations, Inc. (“pre-combination Astra”). Immediately upon the consummation of the Business Combination, Merger Sub merged with and into pre-combination Astra with pre-combination Astra surviving the merger as a wholly owned subsidiary of Holicity. Holicity changed its name to “Astra Space, Inc.” and pre-combination Astra changed its name to “Astra Space Operations, Inc.” Unless the context otherwise requires, “we”, “us”, “our”, “Astra” and the “Company” refers to Astra Space, Inc., the combined company and its subsidiaries following the Business Combination and Astra Space Operations, Inc. prior to the Business Combination. See Note 3 — Acquisitions for further discussion of the Business Combination, included in the Notes to Consolidated Financial Statements in Astra’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission (the "SEC") on March 30, 2023 (“2022 Annual Report”). The Company’s Class A common stock is listed on the Nasdaq under the symbol “ASTR”. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Astra and its subsidiaries, and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for financial reporting. The condensed consolidated financial statements included herein are unaudited, and reflect all adjustments which are, in the opinion of management, of a normal recurring nature and necessary for a fair statement of the results for the periods presented. The condensed consolidated balance sheet data as of December 31, 2022 were derived from Astra’s audited consolidated financial statements included in its 2022 Annual Report. All intercompany transactions and balances have been eliminated in consolidation. The operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 , or for any other future period. Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. The impact of these reclassifications was not material to the condensed financial statements for the periods presented. Liquidity The accompanying unaudited condensed consolidated interim financial statements have been prepared assuming the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these unaudited condensed consolidated interim financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the requirements of ASC Topic 205-40, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern , management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these unaudited condensed consolidated interim financial statements are issued. This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company as of the date the unaudited condensed consolidated interim financial statements are issued. When substantial doubt exists, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the unaudited condensed consolidated interim financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated interim financial statements are issued. The Company evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern over the next twelve months through May 2024. Since inception, the Company has incurred significant operating losses and has an accumulated deficit of approximately $ 1.9 billion . As of March 31, 2023, the Company’s existing sources of liquidity included cash and cash equivalents of $ 16.8 million and marketable securities of $ 45.9 million . The Company believes that its current level of cash and cash equivalents and marketable securities are not sufficient to fund commercial scale production and sale of its services and products. These conditions raise substantial doubt regarding its ability to continue as a going concern for a period of at least one year from the date of issuance of these unaudited condensed consolidated financial statements. On March 10, 2023, the Company became aware that Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (“FDIC”) as receiver. As of March 31, 2023, a portion of the Company’s operating cash is held on deposit with SVB, now a division of First Citizens Bank, and represents approximately 14 % of the Company’s current cash, cash equivalents and marketable securities. The Company’s cash equivalents and marketable securities are held in securities accounts with an affiliate of SVB. While the Company currently has access to the cash on deposit with SVB and such funds are sufficient to meet the Company’s near-term payment obligations, there remains instability in the banking system that could have an effect on other banking institutions to which the Company has transferred funds. Refer to Item 1A. “Risk Factors” for information about the risks related to the liquidity of our deposits with SVB. In order to proceed with the Company’s business plan, the Company will need to raise substantial additional funds through the issuance of additional debt, equity or both. Until such time, if ever, the Company can generate revenue sufficient to achieve profitability, the Company expects to finance its operations through equity or debt financings, which may not be available to the Company on the timing needed or on terms that the Company deems to be favorable. To the extent that the Company raises additional capital through the sale of equity or convertible debt securities, the ownership interest of its stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting the Company’s ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If the Company is unable to obtain sufficient financial resources, its business, financial condition and results of operations will be materially and adversely affected. The Company may be required to delay, limit, reduce or terminate its product development activities or future commercialization efforts. There can be no assurance that the Company will be able to obtain the needed financing on acceptable terms or at all. In an effort to alleviate these conditions, the Company continues to seek and evaluate opportunities to raise additional capital through the issuance of equity or debt securities. As an example, on August 2, 2022, the Company entered into a Common Stock Purchase Agreement ("Purchase Agreement") with B. Riley Principal Capital II LLC ("B. Riley"), which would allow the Company to sell newly issued shares of its Class A Common Stock to B. Riley in aggregate amount not to exceed $ 100.0 million or 19.99 % of the aggregate outstanding Class A and Class B Common Stock of the Company as of August 2, 2022. However, actual sales of shares under the Purchase Agreement will depend on a variety of factors including, among other things, market conditions and the trading price of the Class A Common Stock, and the full amount of capital may not be fully realized. An amendment to the Purchase Agreement would be required to permit sales of Class A Common Stock at a price below the Threshold Price (as defined in the Purchase Agreement). As the Company seeks additional sources of financing, there can be no assurance that such financing would be available to the Company on favorable terms or at all. The Company's ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry. S ee Note 8 – Stockholders’ Equity for additional information about this financing arrangement. As a result of these uncertainties, and notwithstanding management’s plans and efforts to date, there is substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to raise substantial additional capital in the near term, the Company's operations and production plans will be scaled back or curtailed. If the funds raised are insufficient to provide a bridge to full commercial production at a profit, the Company's operations could be severely curtailed or cease entirely and the Company may not realize any significant value from its assets. The Company has, however, prepared these unaudited condensed consolidated financial statements on a going concern basis, assuming that the Company's financial resources will be sufficient to meet our capital needs over the next twelve months. Accordingly, our financial statements do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, marketable securities, and accounts receivable. The Company maintains cash and cash equivalent balances in bank accounts with multiple banking partners. All cash accounts are located in the United States (“U.S.”) and insured by the FDIC up to $ 250,000 . Marketable securities consist of highly liquid investments with financial institutions, which management believes to be of a high credit quality. Our accounts receivable are derived from revenue earned from customers or invoice billed to customer that represent unconditional right to consideration located within the U.S. We mitigate collection risks from our customers by performing regular credit evaluations of our customers’ financial conditions. The Company believes there is no exposure to any significant credit risks related to its cash and cash equivalents or accounts receivable and has not experienced any losses in such accounts. As of March 31, 2023 , three customers accounted fo r 30.9 % , 22.0 % and 15.8 % of the Company’s outstanding trade accounts receivable, respectively. As of December 31, 2022 , three customers accounted for 53.3 %, 21.7 % and 20.8 % of the Company’s outstanding trade accounts receivable, respectively. For the three months ended March 31, 2023 , we had no revenues. For the three months ended March 31, 2022 , one customer accounted fo r 90.9 % of the C ompany’s revenues. Use of Estimates and Judgments The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the unaudited condensed consolidated financial statements and accompanying notes. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ significantly from those estimates. Significant items subject to such estimates and assumptions include the valuation of goodwill and long-lived assets, inventory valuation and reserves, stock-based compensation, pre-combination Astra common stock, useful lives of intangible assets and property, plant and equipment, deferred tax assets, income tax uncertainties, contingent consideration, and other contingencies. Significant Accounting Policies There have been no changes to the Company’s significant accounting policies described in the Company’s 2022 Annual Report that have had a material impact on its unaudited condensed consolidated financial statements and related notes. Recently Issued Accounting Standards Not Yet Adopted In December 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-06, Reference Rate Reform (Topic 848), Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”). In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which provided temporary relief when transitioning from the London Interbank Offered Rate (“LIBOR”) to the Secured Overnight Financing Rate (“SOFR”) or another applicable rate during the original transition period ending on December 31, 2022. In March 2021, the UK Financial Conduct Authority (the “FCA”) announced that the intended cessation date of the overnight 1-, 3-, 6-, and 12-month tenors of U.S. dollar LIBOR would be June 30, 2023, which is beyond the current sunset date of Topic 848. In light of this development, the FASB issued this update to defer the sunset date of Topic 848 from December 31, 2022, to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company does not anticipate this new guidance to have a material impact on its financial position, results of operations, cash flows, or related disclosures.

Revenues

Revenues	3 Months Ended
	Mar. 31, 2023
Revenues [Abstract]
Revenues	Note 2 — Revenues The work performed by the Company in fulfilling Launch Services and Space Products performance obligations is not expected to create an asset to the customer since the launch vehicle that is built to deliver the customer’s payload into orbit will not be owned by the customer nor will the propulsion systems that are built to thrust the customers' satellite into orbit be controlled by the customer until they are delivered to the customer. The Company recognizes revenue at a point in time upon satisfaction of the performance obligations under its Launch Services and Space Products agreements . The following table presents revenue disaggregated by type of revenue for the periods presented: Three Months Ended March 31, 2023 2022 Launch services $ — $ 3,911 Space products — — Total revenues $ — $ 3,911 Contracts with governmental entities involving research and development milestone activities do not represent contracts with customers under ASC 606 and as such, amounts received are recorded in other income in the unaudited condensed consolidated statements of operation s. No such income was recorded for the three months ended March 31, 2023. The Company recorded $ 0.4 million in other income for the three months ended March 31, 2022. Contract balances Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company’s customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Contract assets become receivables once the Company's rights to consideration become unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due. The Company had no contract assets as of March 31, 2023 and December 31, 2022. The Company had contract liabilities of $ 30.0 million and $ 24.1 million as of March 31, 2023 and December 31, 2022, respectively. During the three months ended March 31, 2023, the Company recorded no revenue and $ 2.3 million of revenue during the three months ended March 31, 2022, that was included in the contract liabilities balance at the beginning of the periods. Remaining performance obligations Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. Customers are not considered committed when they are able to terminate their contractual obligations to the Company without payment of a substantive penalty under the contract. The Company had unsatisfied performance obligations of $ 80.6 million as of March 31, 2023, $ 45.5 million of which is expected to be recognized during the remainder of fiscal year 2023, and $ 35.1 million between 2024 and 2028.

Supplemental Financial Informat

Supplemental Financial Information	3 Months Ended
	Mar. 31, 2023
Supplemental Financial Information Abstract
Supplemental Financial Information	Note 3 — Supplemental Financial Information Inventories in thousands March 31, December 31, Raw materials $ 3,631 $ 5,068 Work in progress 3,294 1,520 Finished goods — — Inventories $ 6,925 $ 6,588 There were no invento ry write-downs recorded during the three months ended March 31, 2023. There were $ 5.5 million of inventory write-downs recorded within cost of revenues during the three months ended March 31, 2022. The amounts as of December 31, 2022 have been revised to correct the classification of inventory between raw materials and work in progress. Prepaid and other current assets in thousands March 31, December 31, Deposits $ 5,009 $ 379 Prepaid license and other prepaid expenses 2,608 3,589 Employee Retention Credit - Payroll Tax 2,101 4,283 Other current assets 2,719 2,799 Prepaid and other current assets $ 12,437 $ 11,050 Property, Plant and Equipment, net Presented in the table below are the major classes of property, plant and equipment: in thousands March 31, December 31, Construction in progress $ 7,287 $ 8,309 Computer and software 2,769 2,810 Leasehold improvements 11,645 10,390 Research equipment 8,932 9,042 Production equipment 17,022 14,100 Furniture and fixtures 500 565 Total property, plant and equipment 48,155 45,216 Less: accumulated depreciation ( 21,723 ) ( 20,945 ) Property, plant and equipment, net $ 26,432 $ 24,271 Depreciation expense amounted to $ 0.8 million and $ 2.0 million for the three months ended March 31, 2023 and 2022, respectively. No impairment charges were recorded for the three months ended March 31, 2023 and 2022. Accrued Expenses and Other Current Liabilities in thousands March 31, December 31, Employee compensation and benefits $ 3,571 $ 5,861 Contract liabilities, current portion 29,334 24,137 Construction in progress related accruals 66 2,692 Accrued expenses 4,991 5,179 Accrued inventory purchases 3,886 — Other (miscellaneous) 913 4,174 Accrued expenses and other current liabilities $ 42,761 $ 42,043 Other Non-Current Liabilities in thousands March 31, December 31, Contract liabilities, net of current portion $ 691 $ - Other (miscellaneous) 1,905 1,796 Other non-current liabilities $ 2,596 $ 1,796

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 4 — Intangible Assets in thousands Carrying Amount Accumulated Amortization Net Book Value March 31, 2023 Definite-lived intangible assets Developed technology $ 9,909 $ ( 3,299 ) $ 6,610 Customer contracts and related relationship 2,383 ( 1,544 ) 839 Trade names 123 ( 113 ) 10 Intangible assets subject to amortization 12,415 ( 4,956 ) 7,459 Indefinite-lived intangible assets Trademarks 2,106 — 2,106 Total $ 14,521 $ ( 4,956 ) $ 9,565 There was no impairment charge for the three months ended March 31, 2023 . The Company recorded a pre-tax impairment charge of $ 4.8 million during the third quarter of 2022. The historical costs of the Company's definite-lived intangible assets were adjusted by these impairment charges to derive the carrying amounts in the table above. in thousands Carrying Amount Accumulated Amortization Net Book Value December 31, 2022 Definite-lived intangible assets Developed technology $ 9,909 $ ( 2,910 ) $ 6,999 Customer contracts and related relationship 2,383 ( 1,376 ) 1,007 Trade names 123 ( 103 ) 20 Intangible assets subject to amortization 12,415 ( 4,389 ) 8,026 Indefinite-lived intangible assets Trademarks 2,106 — 2,106 Total $ 14,521 $ ( 4,389 ) $ 10,132 Based on the amount of intangible assets as of March 31, 2023, the expected amortization expense for each of the next five years and thereafter is as follows: in thousands Expected Amortization Expense 2023 (remainder) $ 1,680 2024 1,891 2025 1,555 2026 1,555 2027 778 Total Intangible assets subject to amortization $ 7,459

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 5 — Income Taxes The Company computes its provision for income taxes by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjust the provision for discrete tax items recorded in the period. There has historically been no federal or state provision for income taxes because the Company has incurred operating losses and maintains a full valuation allowance against its net deferred tax assets. For the three months ended March 31, 2023 and 2022 , the Company recognized no provision for income taxes consistent with the losses incurred and the valuation allowance against the deferred tax assets. Utilization of net operating loss carryforwards, tax credits and other attributes may be subject to future annual limitations due to the ownership change limitations provided by Section 382 of the Internal Revenue Code and similar state provisions. The Company files income tax returns in the U.S. federal jurisdiction and various states. The Company is not currently under examination by income tax authorities in federal, state or other jurisdictions. All tax returns will remain open for examination by the federal and state authorities for three and four years, respectively, from the date of utilization of any net operating loss or credits. On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15 % minimum tax on book income of certain large corporations, a 1 % excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on our current analysis of the provisions, we do not believe this legislation will have a material impact on our consolidated financial statements. The Company will continue to monitor for additional guidance related to the Act.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 6 — Fair Value Measurements The Company measures its financial assets and liabilities at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value, as follows: Level 1 Observable inputs, such as quoted prices in active markets for identical assets or liabilities; Level 2 Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and Level 3 Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The Company uses the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The carrying amounts of Company's financial instruments, which include cash equivalents, accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities and certain other current liabilities approximate fair value because of their short-term maturities. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis (in thousands): March 31, 2023 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 2,015 $ — $ — $ 2,015 Marketable securities US Treasury securities 11,859 — — 11,859 Corporate debt securities — 6,962 — 6,962 Commercial paper — 27,123 — 27,123 Total financial assets $ 13,874 $ 34,085 $ — $ 47,959 Liabilities: Contingent consideration $ — $ — $ 31,135 $ 31,135 Total financial liabilities $ — $ — $ 31,135 $ 31,135 December 31, 2022 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 21,909 $ — $ — $ 21,909 Marketable securities US Treasury securities 14,713 — — 14,713 Corporate debt securities — 16,915 — 16,915 Commercial paper — 34,698 — 34,698 Asset backed securities — 2,847 — 2,847 Total financial assets $ 36,622 $ 54,460 $ — $ 91,082 Liabilities: Contingent consideration $ — $ — $ 33,900 $ 33,900 Total financial liabilities $ — $ — $ 33,900 $ 33,900 The following table presents a summary of the changes in fair value of the Company's Level 3 financial instruments: in thousands Contingent Consideration Fair value as of December 31, 2022 $ 33,900 Gain on change in fair value of contingent consideration ( 2,765 ) Fair value as of March 31, 2023 $ 31,135 The fair value of the contingent consideration related to the acquisition of Apollo Fusion, Inc. (“Apollo”) is classified as Level 3 financial instruments. To determine the fair value of the contingent consideration, the Company used a Monte Carlo simulation model. The Monte Carlo simulation considered assumptions including revenue volatilities, risk free rates, discount rates and additional revenue discount rate. Additionally, other key assumptions included forecasted revenues from new customers and probability of achieving it. The following table sets forth the range of inputs for the significant assumptions utilized to determine the fair value of contingent consideration as of March 31, 2023 and December 31, 2022 : March 31, December 31, Risk-free interest rate 3.81 % 4.14 % Expected revenue volatility 19.00 % 19.00 % Revenue discount rate 10.00 % 10.00 % Discount rate 8.00 % 7.50 % The Company began investing in available-for-sale marketable securities in the first quarter of 2022. These marketable securities are classified as short term investments on the unaudited condensed consolidated balance sheets. The following is a summary of available-for-sale marketable securities as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Description Amortized Cost Gross Unrealized Loss Fair Value U.S. Treasury securities $ 11,876 $ ( 17 ) $ 11,859 Corporate debt securities 6,986 ( 24 ) 6,962 Commercial paper 27,123 — 27,123 Total available-for-sale marketable securities $ 45,985 $ ( 41 ) $ 45,944 December 31, 2022 Description Amortized Cost Gross Unrealized Loss Fair Value U.S. Treasury securities $ 14,763 $ ( 50 ) $ 14,713 Corporate debt securities 16,972 ( 57 ) 16,915 Commercial paper 34,698 — 34,698 Asset backed securities 2,850 ( 3 ) 2,847 Total available-for-sale marketable securities $ 69,283 $ ( 110 ) $ 69,173 The following table presents the breakdown of the available-for-sale marketable securities in an unrealized loss position as of March 31, 2023 (in thousands). March 31, 2023 Fair Value Gross Unrealized Loss U.S. Treasury securities Less than 12 months $ 11,859 $ ( 17 ) Total $ 11,859 $ ( 17 ) Corporate debt securities Less than 12 months $ 6,962 $ ( 24 ) Total $ 6,962 $ ( 24 ) Commercial paper Less than 12 months $ 27,123 $ — Total $ 27,123 $ — December 31, 2022 Fair Value Gross Unrealized Loss U.S. Treasury securities Less than 12 months $ 14,713 $ ( 50 ) Total $ 14,713 $ ( 50 ) Corporate debt securities Less than 12 months $ 16,915 $ ( 57 ) Total $ 16,915 $ ( 57 ) Commercial paper Less than 12 months $ 34,698 $ — Total $ 34,698 $ — Asset backed securities Less than 12 months $ 2,847 $ ( 3 ) Total $ 2,847 $ ( 3 ) The Company does not believe these available-for-sale marketable securities to be other-than-temporarily impaired as of March 31, 2023 . There was an unrealized gain of $ 0.1 million on av ailable-for-sale marketable securities during the three months ended March 31, 2023. March 31, 2023 in thousands Amortized Cost Fair Value Due in 1 year or less $ 45,985 $ 45,944 December 31, 2022 in thousands Amortized Cost Fair Value Due in 1 year or less $ 69,283 $ 69,173

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 7 — Commitments and Contingencies Legal Proceedings The Company is party to ordinary and routine litigation incidental to its business. On a case-by-case basis, the Company engages inside and outside counsel to assess the probability of potential liability resulting from such litigation. After making such assessments, the Company makes an accrual for the estimated loss only when the loss is probable, and an amount can be reasonably estimated. The Company and or its current or former directors and officers are currently parties to the following litigation matters: On February 9, 2022, a putative class action was filed in the United States District Court for the Eastern District of New York styled Artery v. Astra Space, Inc. et al., Case No. 1:22-cv-00737 (E.D.N.Y.) (the “Artery Action”). On March 23, 2022, a second putative class action was filed in the United States District Court for the Eastern District of New York styled Riley v. Astra Space, Inc., et al., Case No. 1:22-cv-01591 (E.D.N.Y.) (the “Riley Action”). On November 14, 2022, the Artery Action and the Riley Action were consolidated into a single action (the “Securities Action”), restyled In re Astra Space Inc. f/k/a Holicity Inc. Securities Litigation, and Lead Plaintiffs were appointed. On December 14, 2022, the Securities Action was transferred to the United States District Court for the Northern District of California under Case No. 3:22-cv-08875. On December 28, 2022, Lead Plaintiffs filed their amended complaint. The amended complaint alleges that the Company and several of its current and former officers and directors violated provisions of the Securities Exchange Act of 1934 with respect to certain statements concerning the Company’s projected launch cadence and payload capacity goals. The amended complaint seeks unspecified damages on behalf of a purported class of purchasers of the Company’s securities between February 2, 2021 and December 29, 2021. Defendants moved to dismiss on December 28, 2022. Briefing on that motion is expected to be complete in June 2023. The Company believes that the Securities Action is without merit and intends to defend it vigorously. Due to the early stage of the cases, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined. On April 27, 2022, a stockholder derivative suit was filed in the United States District Court for the Eastern District of New York styled Gonzalez v. Kemp, et al., Case No. 22-cv-02401 (E.D.N.Y.) (the “Gonzalez Action”). On January 25, 2023, the plaintiff filed an amended complaint. The amended complaint asserts claims against certain of the Company’s current and former officers and directors for alleged breaches of their fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, waste of corporate assets, alleged violations of Section 14(a) of the Securities Exchange Act of 1934 (the “Exchange Act”), and for contribution under Section 10(b) and 21D of the Exchange Act based upon the conduct alleged in the Securities Action described above. The plaintiff in the Gonzalez Action seeks monetary damages in favor of the Company in an unstated amount, reforms to the Company’s corporate governance and internal procedures, restitution including disgorgement of any compensation, profits or other benefits received, and reimbursement of the plaintiff's reasonable fees and costs, including attorney’s fees. On February 17, 2023, the Gonzalez Action was transferred to the United States District Court for the Northern District of California under Case No. 3:23-cv-00713. Defendants filed a motion to dismiss the amended complaint on April 18, 2023. The Company believes that the case is without merit and intends to defend it vigorously. Due to the early stage of the case, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined. The Company has tendered defense of each of the foregoing claims under its Directors’ and Officers’ policy. The retention under this policy is $ 20.0 million. Indemnification Obligations to former Company Board Members On May 20, 2022, a putative class action was filed in the Court of Chancery of the State of Delaware styled Newbold v. McCaw et. al., Case No. 2022-0439 (the “Newbold Action”). The complaint alleges that Pendrell Corporation, X-icity Holdings Corporation f/k/a Pendrell Holicity Holdings and certain former officers, directors or controlling stockholders of Holicity, Inc. n/k/a Astra Space, Inc., breached their fiduciary duties to the Company in closing on the Business Combination. The complaint seeks unspecified damages on behalf of a purported class of stockholders of the Company’s securities from June 28, 2021 through June 30, 2021. Neither the Company nor any of its board members are parties in this action. Mr. McCaw, who served as a former member of the Company’s board, is a defendant in this action, but the allegations relate to periods prior to the Business Combination. Astra is obligated to indemnify certain of the defendants in the Newbold Action. The Company has tendered defense of this action under its Directors’ and Officers' Policy. The Company also tendered defense of this claim under the tail policy it was required to purchase in connection with the Business Combination. The retention under the tail policy is $ 1.5 million. Due to the early stage of this case, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined. Delaware Court of Chancery Approval of Petition relating to Amendment to Increase Authorized Shares On March 1, 2023, the Company filed a petition in the Delaware Court of Chancery (the “Court of Chancery”) seeking validation of the amendment of its certificate of incorporation in connection with the Business Combination to increase its authorized shares of Common Stock (the “Charter Amendment”) as a result of uncertainty regarding the validity of such amendment given a recent decision of the Court of Chancery. On March 14, 2023, the Court of Chancery validated and declared effective the Charter Amendment, increasing the Company’s authorized Common Stock from 220,000,000 to 465,000,000 , thereby permitting the Company to issue additional shares of Class A and Class B common stock in connection with the Business Combination and thereafter. Purchase Commitments In order to reduce manufacturing lead times and to have access to an adequate supply of components, the Company enters into agreements with certain suppliers to procure component inventory based on the Company's production needs. A significant portion of the Company's purchase commitments arising from these agreements consist of firm and non-cancelable commitments. As of March 31, 2023, the Company had $ 28.4 million outstanding purchase commitments whose terms run through May 2026. Payments will be made against these supplier contracts as deliveries occur throughout the term.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 8 — Stockholders’ Equity Common and Preferred Stock As of March 31, 2023, the Company had authorized a total of 466,000,000 shares of stock, consisting of (i) 400,000,000 shares of Class A common stock, par value $ 0.0001 per share (“Class A common stock”), (ii) 65,000,000 shares of Class B common stock, par value $ 0.0001 per share (“Class B common stock”), and (iii) 1,000,000 shares of preferred stock, par value $ 0.0001 per share (“Preferred Stock”). As of March 31, 2023, the Company had 215,286,444 and 55,539,188 shares of Class A and Class B common stock issued and outstanding, respectively. There were no shares of preferred stock outstanding as of March 31, 2023. Holders of the Class A and Class B common stock have identical distribution rights, except that holders of the Class A common stock are entitled to one vote per share and holders of the Class B common stock are entitled to ten votes per share. Each share of Class B common stock can be converted into one share of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in the Company's amended and restated certificate of incorporation. Common Stock Purchase Agreement On August 2, 2022, the Company entered into a Common Stock Purchase Agreement and a Registration Rights Agreement (the “Registration Rights Agreement”) with B. Riley. Pursuant to the Purchase Agreement, the Company will have the right to sell to B. Riley up to the lesser of (i) $ 100.0 million of newly issued shares (the “Shares”) of the Class A Common Stock, and (ii) 53,059,650 Shares of Class A common stock, which number of shares is equal to 19.99 % of the sum of Class A common stock and Class B common stock issued and outstanding immediately prior to the execution of the Purchase Agreement (subject to certain conditions and limitations), from time to time during the term of the Purchase Agreement. However, the Purchase Agreement prohibits the Company from issuing or selling any shares of Class A common stock to B. Riley if such a sale, when aggregated with all other shares of Class A common stock then beneficially owned by B. Riley and its affiliates, would result in B. Riley beneficially owning more than 4.99 % of the outstanding shares of Class A common stock . Sales of the Shares pursuant to the Purchase Agreement, and the timing of any sales, are solely at the option of the Company beginning on September 13, 2022. Actual sales of Shares to B. Riley under the Purchase Agreement will depend on a variety of factors including, among other things: market conditions, the trading price of the Class A common stock, and determinations by the Company as to the appropriate sources of funding for the Company and its operations. An amendment to the Common Stock Purchase Agreement is required to sell shares at a price less than the Threshold Price (as defined in the Purchase Agreement). The purchase price of the Class A common stock that the Company may sell to B. Riley pursuant to the Purchase Agreement will be 97 % of the average of the volume weighted average price of the Company’s Class A common stock as calculated per the terms set forth in the Purchase Agreement. The net proceeds from sales, if any, under the Purchase Agreement, will depend on the frequency and prices at which the Company sells the Shares of Class A common stock. To the extent the Company sells the Shares of Class A common stock under the Purchase Agreement, the Company currently plans to use any proceeds for working capital and general corporate purposes.

Stock-based Compensation

Stock-based Compensation	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement	Note 9 — Stock-based Compensation Stock-based incentive awards are provided to employees under the terms of Astra's 2021 Omnibus Incentive Plan (the “2021 Plan”) and 2021 Employee Stock Purchase Plan (the “2021 ESPP”). Under the 2021 Plan, the Company grants restricted stock units (“RSUs”), Performance-Based Units ("PSUs"), time-based stock options and performance stock options ("PSOs") to its executive officers. RSUs and time-based stock options granted have service-based vesting conditions only. PSUs granted have service and performance conditions. The service conditions vary for each executive officer and is based on their continued service to the Company. Stock option holders have a 10-year period to exercise their options before options expire. In July 2022, the PSU agreements were amended to remove the performance-based vesting conditions and only retain the time-based vesting condition. Forfeitures are recognized in the period of occurrence and stock-based compensation costs are recognized based on grant-date fair value as RSUs and time-based stock options vest. The 2021 ESPP, which is maintained by the Company, allows employees to purchase the Company’s common stock at a discount of up to 15 % of the lesser of the fair market value at the beginning of the offering period or the end of each six-month purchase period . 0.8 million shares were issued under the 2021 ESPP during the three months ended March 31, 2023. As of March 31, 2023, 9.1 million shares remain available for issuance under the 2021 ESPP. As of March 31, 2023, the Company had $ 0.4 million of unrecognized stock-based compensation expense related to the 2021 ESPP. This cost is expected to be recognized over a weighted-average period of 0.77 years. The following table summarizes stock-based compensation expense that the Company recorded in the unaudited condensed consolidated statements of operations for the three months ended March 31, 2023 and 2022: Three Months Ended in thousands 2023 2022 Cost of revenues $ — $ 241 Research and development 2,359 6,736 Sales and marketing 380 1,580 General and administrative 2,589 8,484 Stock-based compensation expense $ 5,328 $ 17,041 The Company recognized $ 0.1 million and $ 1.0 million compensation costs related to PSUs for the three months ended March 31, 2023 and 2022, respectively, to reflect the PSUs that satisfied the time-based vesting condition on the time-vesting dates. As of March 31, 2023, the Company had $ 56.4 million of unrecognized stock-based compensation expense related to all of the Company's stock-based awards. This cost is expected to be recognized over a weighted-average period of 3.0 years. Stock Options Awards The following is a summary of stock option activity for the three months ended March 31, 2023 and 2022: No. of Weighted- Average Exercise Price Weighted- Average Aggregate Intrinsic Outstanding - December 31, 2021 20,326,384 $ 7.52 9.4 $ 22,782,654 Granted 1,142,027 5.21 9.8 Exercised ( 176,774 ) 0.45 4.4 783,216 Forfeited ( 24,661 ) 2.93 — — Expired ( 1,465 ) 6.75 — — Outstanding - March 31, 2022 21,265,511 $ 7.46 9.2 $ 11,290,701 Outstanding – December 31, 2022 16,248,601 $ 7.11 8.4 $ 9,630 Granted 10,535,783 0.55 1.5 — Exercised ( 180,923 ) 0.46 0.4 — Forfeited ( 878,620 ) 0.65 — — Expired ( 23,330 ) 1.65 — — Outstanding – March 31, 2023 25,701,511 $ 4.69 8.8 $ 10,124 Unvested – March 31, 2023 22,171,996 $ 4.94 9.2 $ 2,184 Exercisable – March 31, 2023 3,529,515 $ 3.14 7.5 $ 7,940 The Company uses the Black-Scholes option pricing-model to calculate the grant date fair value of time-based options. The following table summarizes the assumptions used in estimating the fair value of options granted in the three months ended March 31, 2023 and 2022: Three Months Ended 2023 2022 Expected terms (years) (1) 6.71 5.81 Expected volatility (2) 98.2 % 68.9 % Risk-free interest rate (3) 3.46 % 1.70 % Expected dividend rate (4) — — Grant-date fair value $ 0.42 - $ 0.56 $ 3.20 ____________ (1) The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. (2) Expected volatility, or the standard deviation of annualized returns, was calculated based on comparable companies’ reported volatilities. (3) Risk-free interest was obtained from U.S. treasury notes for the expected terms noted as of the valuation date . (4) The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future . Restricted Stock Units Awards The following is a summary of restricted stock units for the three months ended March 31, 2023 and 2022: Number of RSUs Outstanding Weighted- Average Grant Date Fair Value Per Share Outstanding - December 31, 2021 10,678,818 $ 9.20 Granted 3,937,226 4.25 Vested ( 828,680 ) 8.64 Forfeited ( 328,562 ) 9.23 Outstanding - March 31, 2022 13,458,802 $ 7.78 Outstanding – December 31, 2022 16,121,844 $ 3.35 Granted 990,959 0.52 Vested ( 627,185 ) 6.51 Forfeited ( 1,944,250 ) 3.71 Outstanding – March 31, 2023 14,541,368 $ 2.97 Total fair value as of the respective vesting dates of restricted stock units vested for the three months ended March 31, 2023 was approximately $ 0.8 million. As of March 31, 2023, the aggregate intrinsic value of unvested restricted stock units was $ 6.2 million.

Loss per Share

Loss per Share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Loss per Share	Note 10 — Loss per Share The Company computes earnings per share of Common Stock using the two-class method required for participating securities. Basic and diluted earnings per share were the same for the periods presented as the inclusion of all potential Common Stock outstanding would have been anti-dilutive. Earnings per share calculations for all periods prior to the Business Combination have been retrospectively restated to the equivalent number of shares reflecting the exchange ratio established in the BCA. Subsequent to the Business Combination, earnings per share was calculated based on weighted average number of shares of common stock then outstanding. The following tables set forth the computation of basic and diluted loss for the three months ended March 31, 2023 and 2022: Three Months Ended March 31, 2023 2022 (in thousands, except share and per share amounts) Class A Class B Class A Class B Net loss attributed to common stockholders $ ( 35,667 ) $ ( 9,226 ) $ ( 67,657 ) $ ( 18,056 ) Basic weighted average common shares outstanding 214,706,779 55,539,188 208,112,630 55,539,188 Dilutive weighted average common shares outstanding 214,706,779 55,539,188 208,112,630 55,539,188 Loss per share attributable to common stockholders: Basic and Diluted loss per share $ ( 0.17 ) $ ( 0.17 ) $ ( 0.33 ) $ ( 0.33 ) There were no preferred dividends declared or accumulated as of March 31, 2023 . The following Class A securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive: March 31, 2023 2022 Stock options 15,939,378 8,249,326 RSUs 14,533,186 13,359,326 Warrants 25,000 — Total 30,497,564 21,608,652 There were no Cla ss B securities that were excluded in the computation of diluted shares outstanding for the three months ended March 31, 2023 and 2022 .

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Segment Information	Note 11 — Segment Information The Company reports segment information based on a “management” approach to reflect the operating segments for which the Company’s Chief Executive Officer, as the Chief Operating Decision Maker (“CODM”), makes decisions and assesses performance. Prior to the current reporting period, the Company had a single operating and reportable segment. Following commencement of revenue-generating activities for Space Products (as defined below) during the third quarter of fiscal year 2022, the Company restructured the management, operations, and periodic management and internal reporting packages to address the shift in strategy. As a result of these changes, the Company determined that its reportable segments had changed and that beginning in the third quarter of 2022 the Company has two operating and reportable segments: Launch Services and Space Products. The Company recast prior period information related to the change in segments. Launch Services segment provides launch services to satellite operators and governments in partnership with third-party spaceport providers globally. Space Products consist of designing and providing space products based on the customers' needs for a successful satellite launch and other products that the Company may sell in the future. The following table shows revenue by reportable segment for the three months ended March 31, 2023 and 2022: Three Months Ended (in thousands) 2023 2022 Revenues: Launch services $ — $ 3,911 Space products — — Total revenues: $ — $ 3,911 Cost of revenues: Launch services $ — $ 11,014 Space products — — Total cost of revenues: $ — $ 11,014 Gross profit (loss): Launch services $ — $ ( 7,103 ) Space products — — Total gross profit (loss): $ — $ ( 7,103 ) The Company evaluates the performance of its reportable segments based on segment gross profit. Segment gross profit is segment revenue less segment cost of revenue. Unallocated expenses include operating expenses related to research and development, selling and marketing and general and administrative expenses as they are not considered when management evaluates segment performance. The following table reconciles segment gross profit to loss before income taxes for the three months ended March 31, 2023 and 2022: Three Months Ended (in thousands) 2023 2022 Gross profit (loss) $ — $ ( 7,103 ) Research and development 31,082 37,927 Selling and marketing 2,484 4,764 General and administrative 15,682 20,986 Loss (Gain) on change in fair value of contingent consideration ( 2,765 ) 15,500 Interest (income) expense, net ( 1,330 ) ( 174 ) Other expense (income), net ( 260 ) ( 393 ) Loss before taxes $ ( 44,893 ) $ ( 85,713 ) The Company does not evaluate performance or allocate resources based on reporting segment’s total assets or operating expenses, and therefore such information is not presented. All of the Company’s long-lived assets are located in the United States. The Company is subject to International Traffic in Arms Regulations (“ITAR”) and generates all of its revenue in the United States.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Astra and its subsidiaries, and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for financial reporting. The condensed consolidated financial statements included herein are unaudited, and reflect all adjustments which are, in the opinion of management, of a normal recurring nature and necessary for a fair statement of the results for the periods presented. The condensed consolidated balance sheet data as of December 31, 2022 were derived from Astra’s audited consolidated financial statements included in its 2022 Annual Report. All intercompany transactions and balances have been eliminated in consolidation. The operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 , or for any other future period.
Reclassifications	Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. The impact of these reclassifications was not material to the condensed financial statements for the periods presented.
Liquidity	Liquidity The accompanying unaudited condensed consolidated interim financial statements have been prepared assuming the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these unaudited condensed consolidated interim financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the requirements of ASC Topic 205-40, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern , management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these unaudited condensed consolidated interim financial statements are issued. This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company as of the date the unaudited condensed consolidated interim financial statements are issued. When substantial doubt exists, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the unaudited condensed consolidated interim financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated interim financial statements are issued. The Company evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern over the next twelve months through May 2024. Since inception, the Company has incurred significant operating losses and has an accumulated deficit of approximately $ 1.9 billion . As of March 31, 2023, the Company’s existing sources of liquidity included cash and cash equivalents of $ 16.8 million and marketable securities of $ 45.9 million . The Company believes that its current level of cash and cash equivalents and marketable securities are not sufficient to fund commercial scale production and sale of its services and products. These conditions raise substantial doubt regarding its ability to continue as a going concern for a period of at least one year from the date of issuance of these unaudited condensed consolidated financial statements. On March 10, 2023, the Company became aware that Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (“FDIC”) as receiver. As of March 31, 2023, a portion of the Company’s operating cash is held on deposit with SVB, now a division of First Citizens Bank, and represents approximately 14 % of the Company’s current cash, cash equivalents and marketable securities. The Company’s cash equivalents and marketable securities are held in securities accounts with an affiliate of SVB. While the Company currently has access to the cash on deposit with SVB and such funds are sufficient to meet the Company’s near-term payment obligations, there remains instability in the banking system that could have an effect on other banking institutions to which the Company has transferred funds. Refer to Item 1A. “Risk Factors” for information about the risks related to the liquidity of our deposits with SVB. In order to proceed with the Company’s business plan, the Company will need to raise substantial additional funds through the issuance of additional debt, equity or both. Until such time, if ever, the Company can generate revenue sufficient to achieve profitability, the Company expects to finance its operations through equity or debt financings, which may not be available to the Company on the timing needed or on terms that the Company deems to be favorable. To the extent that the Company raises additional capital through the sale of equity or convertible debt securities, the ownership interest of its stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting the Company’s ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If the Company is unable to obtain sufficient financial resources, its business, financial condition and results of operations will be materially and adversely affected. The Company may be required to delay, limit, reduce or terminate its product development activities or future commercialization efforts. There can be no assurance that the Company will be able to obtain the needed financing on acceptable terms or at all. In an effort to alleviate these conditions, the Company continues to seek and evaluate opportunities to raise additional capital through the issuance of equity or debt securities. As an example, on August 2, 2022, the Company entered into a Common Stock Purchase Agreement ("Purchase Agreement") with B. Riley Principal Capital II LLC ("B. Riley"), which would allow the Company to sell newly issued shares of its Class A Common Stock to B. Riley in aggregate amount not to exceed $ 100.0 million or 19.99 % of the aggregate outstanding Class A and Class B Common Stock of the Company as of August 2, 2022. However, actual sales of shares under the Purchase Agreement will depend on a variety of factors including, among other things, market conditions and the trading price of the Class A Common Stock, and the full amount of capital may not be fully realized. An amendment to the Purchase Agreement would be required to permit sales of Class A Common Stock at a price below the Threshold Price (as defined in the Purchase Agreement). As the Company seeks additional sources of financing, there can be no assurance that such financing would be available to the Company on favorable terms or at all. The Company's ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry. S ee Note 8 – Stockholders’ Equity for additional information about this financing arrangement. As a result of these uncertainties, and notwithstanding management’s plans and efforts to date, there is substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to raise substantial additional capital in the near term, the Company's operations and production plans will be scaled back or curtailed. If the funds raised are insufficient to provide a bridge to full commercial production at a profit, the Company's operations could be severely curtailed or cease entirely and the Company may not realize any significant value from its assets. The Company has, however, prepared these unaudited condensed consolidated financial statements on a going concern basis, assuming that the Company's financial resources will be sufficient to meet our capital needs over the next twelve months. Accordingly, our financial statements do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, marketable securities, and accounts receivable. The Company maintains cash and cash equivalent balances in bank accounts with multiple banking partners. All cash accounts are located in the United States (“U.S.”) and insured by the FDIC up to $ 250,000 . Marketable securities consist of highly liquid investments with financial institutions, which management believes to be of a high credit quality. Our accounts receivable are derived from revenue earned from customers or invoice billed to customer that represent unconditional right to consideration located within the U.S. We mitigate collection risks from our customers by performing regular credit evaluations of our customers’ financial conditions. The Company believes there is no exposure to any significant credit risks related to its cash and cash equivalents or accounts receivable and has not experienced any losses in such accounts. As of March 31, 2023 , three customers accounted fo r 30.9 % , 22.0 % and 15.8 % of the Company’s outstanding trade accounts receivable, respectively. As of December 31, 2022 , three customers accounted for 53.3 %, 21.7 % and 20.8 % of the Company’s outstanding trade accounts receivable, respectively. For the three months ended March 31, 2023 , we had no revenues. For the three months ended March 31, 2022 , one customer accounted fo r 90.9 % of the C ompany’s revenues.
Use of Estimates and Judgements	Use of Estimates and Judgments The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the unaudited condensed consolidated financial statements and accompanying notes. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ significantly from those estimates. Significant items subject to such estimates and assumptions include the valuation of goodwill and long-lived assets, inventory valuation and reserves, stock-based compensation, pre-combination Astra common stock, useful lives of intangible assets and property, plant and equipment, deferred tax assets, income tax uncertainties, contingent consideration, and other contingencies.
Recently Adopted Accounting Guidance	Recently Issued Accounting Standards Not Yet Adopted In December 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2022-06, Reference Rate Reform (Topic 848), Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”). In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which provided temporary relief when transitioning from the London Interbank Offered Rate (“LIBOR”) to the Secured Overnight Financing Rate (“SOFR”) or another applicable rate during the original transition period ending on December 31, 2022. In March 2021, the UK Financial Conduct Authority (the “FCA”) announced that the intended cessation date of the overnight 1-, 3-, 6-, and 12-month tenors of U.S. dollar LIBOR would be June 30, 2023, which is beyond the current sunset date of Topic 848. In light of this development, the FASB issued this update to defer the sunset date of Topic 848 from December 31, 2022, to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company does not anticipate this new guidance to have a material impact on its financial position, results of operations, cash flows, or related disclosures.

Revenues (Tables)

Revenues (Tables)	3 Months Ended
	Mar. 31, 2023
Revenues [Abstract]
Schedule of Revenue Disaggregated by Type of Revenue	The following table presents revenue disaggregated by type of revenue for the periods presented: Three Months Ended March 31, 2023 2022 Launch services $ — $ 3,911 Space products — — Total revenues $ — $ 3,911

Supplemental Financial Inform_2

Supplemental Financial Information (Tables)	3 Months Ended
	Mar. 31, 2023
Supplemental Financial Information Abstract
Schedule of Inventory	Inventories in thousands March 31, December 31, Raw materials $ 3,631 $ 5,068 Work in progress 3,294 1,520 Finished goods — — Inventories $ 6,925 $ 6,588
Schedule of Prepaid and Other Current Assets	Prepaid and other current assets in thousands March 31, December 31, Deposits $ 5,009 $ 379 Prepaid license and other prepaid expenses 2,608 3,589 Employee Retention Credit - Payroll Tax 2,101 4,283 Other current assets 2,719 2,799 Prepaid and other current assets $ 12,437 $ 11,050
Schedule of Major Classes of Property Plant and Equipment	Property, Plant and Equipment, net Presented in the table below are the major classes of property, plant and equipment: in thousands March 31, December 31, Construction in progress $ 7,287 $ 8,309 Computer and software 2,769 2,810 Leasehold improvements 11,645 10,390 Research equipment 8,932 9,042 Production equipment 17,022 14,100 Furniture and fixtures 500 565 Total property, plant and equipment 48,155 45,216 Less: accumulated depreciation ( 21,723 ) ( 20,945 ) Property, plant and equipment, net $ 26,432 $ 24,271
Schedule of Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities in thousands March 31, December 31, Employee compensation and benefits $ 3,571 $ 5,861 Contract liabilities, current portion 29,334 24,137 Construction in progress related accruals 66 2,692 Accrued expenses 4,991 5,179 Accrued inventory purchases 3,886 — Other (miscellaneous) 913 4,174 Accrued expenses and other current liabilities $ 42,761 $ 42,043
Schedule of Other Non-Current Liabilities	Other Non-Current Liabilities in thousands March 31, December 31, Contract liabilities, net of current portion $ 691 $ - Other (miscellaneous) 1,905 1,796 Other non-current liabilities $ 2,596 $ 1,796

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Other Intangible Assets	in thousands Carrying Amount Accumulated Amortization Net Book Value March 31, 2023 Definite-lived intangible assets Developed technology $ 9,909 $ ( 3,299 ) $ 6,610 Customer contracts and related relationship 2,383 ( 1,544 ) 839 Trade names 123 ( 113 ) 10 Intangible assets subject to amortization 12,415 ( 4,956 ) 7,459 Indefinite-lived intangible assets Trademarks 2,106 — 2,106 Total $ 14,521 $ ( 4,956 ) $ 9,565 in thousands Carrying Amount Accumulated Amortization Net Book Value December 31, 2022 Definite-lived intangible assets Developed technology $ 9,909 $ ( 2,910 ) $ 6,999 Customer contracts and related relationship 2,383 ( 1,376 ) 1,007 Trade names 123 ( 103 ) 20 Intangible assets subject to amortization 12,415 ( 4,389 ) 8,026 Indefinite-lived intangible assets Trademarks 2,106 — 2,106 Total $ 14,521 $ ( 4,389 ) $ 10,132
Expected Future Amortization Expense Related to Intangible Assets	Based on the amount of intangible assets as of March 31, 2023, the expected amortization expense for each of the next five years and thereafter is as follows: in thousands Expected Amortization Expense 2023 (remainder) $ 1,680 2024 1,891 2025 1,555 2026 1,555 2027 778 Total Intangible assets subject to amortization $ 7,459

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of fair value hierarchy	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis (in thousands): March 31, 2023 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 2,015 $ — $ — $ 2,015 Marketable securities US Treasury securities 11,859 — — 11,859 Corporate debt securities — 6,962 — 6,962 Commercial paper — 27,123 — 27,123 Total financial assets $ 13,874 $ 34,085 $ — $ 47,959 Liabilities: Contingent consideration $ — $ — $ 31,135 $ 31,135 Total financial liabilities $ — $ — $ 31,135 $ 31,135 December 31, 2022 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 21,909 $ — $ — $ 21,909 Marketable securities US Treasury securities 14,713 — — 14,713 Corporate debt securities — 16,915 — 16,915 Commercial paper — 34,698 — 34,698 Asset backed securities — 2,847 — 2,847 Total financial assets $ 36,622 $ 54,460 $ — $ 91,082 Liabilities: Contingent consideration $ — $ — $ 33,900 $ 33,900 Total financial liabilities $ — $ — $ 33,900 $ 33,900
Summary of the Changes In Fair Value of Financial Instruments	The following table presents a summary of the changes in fair value of the Company's Level 3 financial instruments: in thousands Contingent Consideration Fair value as of December 31, 2022 $ 33,900 Gain on change in fair value of contingent consideration ( 2,765 ) Fair value as of March 31, 2023 $ 31,135
Summary of Range of Inputs To Determine The Fair Value of Contingent Consideration	The following table sets forth the range of inputs for the significant assumptions utilized to determine the fair value of contingent consideration as of March 31, 2023 and December 31, 2022 :
Summary of Available-for-Sale Marketable Securities	The following is a summary of available-for-sale marketable securities as of March 31, 2023 and December 31, 2022 (in thousands): March 31, 2023 Description Amortized Cost Gross Unrealized Loss Fair Value U.S. Treasury securities $ 11,876 $ ( 17 ) $ 11,859 Corporate debt securities 6,986 ( 24 ) 6,962 Commercial paper 27,123 — 27,123 Total available-for-sale marketable securities $ 45,985 $ ( 41 ) $ 45,944 December 31, 2022 Description Amortized Cost Gross Unrealized Loss Fair Value U.S. Treasury securities $ 14,763 $ ( 50 ) $ 14,713 Corporate debt securities 16,972 ( 57 ) 16,915 Commercial paper 34,698 — 34,698 Asset backed securities 2,850 ( 3 ) 2,847 Total available-for-sale marketable securities $ 69,283 $ ( 110 ) $ 69,173
Schedule of Breakdown of the Available-for-Sale Marketable Securities in an Unrealized Loss Position	The following table presents the breakdown of the available-for-sale marketable securities in an unrealized loss position as of March 31, 2023 (in thousands). March 31, 2023 Fair Value Gross Unrealized Loss U.S. Treasury securities Less than 12 months $ 11,859 $ ( 17 ) Total $ 11,859 $ ( 17 ) Corporate debt securities Less than 12 months $ 6,962 $ ( 24 ) Total $ 6,962 $ ( 24 ) Commercial paper Less than 12 months $ 27,123 $ — Total $ 27,123 $ — December 31, 2022 Fair Value Gross Unrealized Loss U.S. Treasury securities Less than 12 months $ 14,713 $ ( 50 ) Total $ 14,713 $ ( 50 ) Corporate debt securities Less than 12 months $ 16,915 $ ( 57 ) Total $ 16,915 $ ( 57 ) Commercial paper Less than 12 months $ 34,698 $ — Total $ 34,698 $ — Asset backed securities Less than 12 months $ 2,847 $ ( 3 ) Total $ 2,847 $ ( 3 )
Summary of amortized cost and fair value of available-for-sale securities by contractual maturity	March 31, 2023 in thousands Amortized Cost Fair Value Due in 1 year or less $ 45,985 $ 45,944 December 31, 2022 in thousands Amortized Cost Fair Value Due in 1 year or less $ 69,283 $ 69,173

Stock-based Compensation (Table

Stock-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Summary of Share-based Compensation	The following table summarizes stock-based compensation expense that the Company recorded in the unaudited condensed consolidated statements of operations for the three months ended March 31, 2023 and 2022: Three Months Ended in thousands 2023 2022 Cost of revenues $ — $ 241 Research and development 2,359 6,736 Sales and marketing 380 1,580 General and administrative 2,589 8,484 Stock-based compensation expense $ 5,328 $ 17,041
Summary of Stock Option Activity	The following is a summary of stock option activity for the three months ended March 31, 2023 and 2022: No. of Weighted- Average Exercise Price Weighted- Average Aggregate Intrinsic Outstanding - December 31, 2021 20,326,384 $ 7.52 9.4 $ 22,782,654 Granted 1,142,027 5.21 9.8 Exercised ( 176,774 ) 0.45 4.4 783,216 Forfeited ( 24,661 ) 2.93 — — Expired ( 1,465 ) 6.75 — — Outstanding - March 31, 2022 21,265,511 $ 7.46 9.2 $ 11,290,701 Outstanding – December 31, 2022 16,248,601 $ 7.11 8.4 $ 9,630 Granted 10,535,783 0.55 1.5 — Exercised ( 180,923 ) 0.46 0.4 — Forfeited ( 878,620 ) 0.65 — — Expired ( 23,330 ) 1.65 — — Outstanding – March 31, 2023 25,701,511 $ 4.69 8.8 $ 10,124 Unvested – March 31, 2023 22,171,996 $ 4.94 9.2 $ 2,184 Exercisable – March 31, 2023 3,529,515 $ 3.14 7.5 $ 7,940 The Company uses the Black-Scholes option pricing-model to calculate the grant date fair value of time-based options. The following table summarizes the assumptions used in estimating the fair value of options granted in the three months ended March 31, 2023 and 2022: Three Months Ended 2023 2022 Expected terms (years) (1) 6.71 5.81 Expected volatility (2) 98.2 % 68.9 % Risk-free interest rate (3) 3.46 % 1.70 % Expected dividend rate (4) — — Grant-date fair value $ 0.42 - $ 0.56 $ 3.20 ____________ (1) The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. (2) Expected volatility, or the standard deviation of annualized returns, was calculated based on comparable companies’ reported volatilities. (3) Risk-free interest was obtained from U.S. treasury notes for the expected terms noted as of the valuation date . (4) The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future .
Summary of restricted stock units	The following is a summary of restricted stock units for the three months ended March 31, 2023 and 2022: Number of RSUs Outstanding Weighted- Average Grant Date Fair Value Per Share Outstanding - December 31, 2021 10,678,818 $ 9.20 Granted 3,937,226 4.25 Vested ( 828,680 ) 8.64 Forfeited ( 328,562 ) 9.23 Outstanding - March 31, 2022 13,458,802 $ 7.78 Outstanding – December 31, 2022 16,121,844 $ 3.35 Granted 990,959 0.52 Vested ( 627,185 ) 6.51 Forfeited ( 1,944,250 ) 3.71 Outstanding – March 31, 2023 14,541,368 $ 2.97

Loss per Share (Tables)

Loss per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Loss	The following tables set forth the computation of basic and diluted loss for the three months ended March 31, 2023 and 2022: Three Months Ended March 31, 2023 2022 (in thousands, except share and per share amounts) Class A Class B Class A Class B Net loss attributed to common stockholders $ ( 35,667 ) $ ( 9,226 ) $ ( 67,657 ) $ ( 18,056 ) Basic weighted average common shares outstanding 214,706,779 55,539,188 208,112,630 55,539,188 Dilutive weighted average common shares outstanding 214,706,779 55,539,188 208,112,630 55,539,188 Loss per share attributable to common stockholders: Basic and Diluted loss per share $ ( 0.17 ) $ ( 0.17 ) $ ( 0.33 ) $ ( 0.33 )
Schedule of Antidilutive Shares	The following Class A securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive: March 31, 2023 2022 Stock options 15,939,378 8,249,326 RSUs 14,533,186 13,359,326 Warrants 25,000 — Total 30,497,564 21,608,652 There were no Cla ss B securities that were excluded in the computation of diluted shares outstanding for the three months ended March 31, 2023 and 2022 .

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Schedule of Revenue by Reportable Segment	The following table shows revenue by reportable segment for the three months ended March 31, 2023 and 2022: Three Months Ended (in thousands) 2023 2022 Revenues: Launch services $ — $ 3,911 Space products — — Total revenues: $ — $ 3,911 Cost of revenues: Launch services $ — $ 11,014 Space products — — Total cost of revenues: $ — $ 11,014 Gross profit (loss): Launch services $ — $ ( 7,103 ) Space products — — Total gross profit (loss): $ — $ ( 7,103 )
Summary of Reconciles Segment Gross Profit to Loss Before Income Taxes	The following table reconciles segment gross profit to loss before income taxes for the three months ended March 31, 2023 and 2022: Three Months Ended (in thousands) 2023 2022 Gross profit (loss) $ — $ ( 7,103 ) Research and development 31,082 37,927 Selling and marketing 2,484 4,764 General and administrative 15,682 20,986 Loss (Gain) on change in fair value of contingent consideration ( 2,765 ) 15,500 Interest (income) expense, net ( 1,330 ) ( 174 ) Other expense (income), net ( 260 ) ( 393 ) Loss before taxes $ ( 44,893 ) $ ( 85,713 )

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Additional information (Detail)			3 Months Ended		12 Months Ended
	Mar. 10, 2023	Aug. 02, 2022 USD ($)	Mar. 31, 2023 USD ($) Customers	Mar. 31, 2022 Customers	Dec. 31, 2022 USD ($) Customers
Accounting Policy [Line Items]
Cash and cash equivalents			$ 16,805,000		$ 33,644,000
Marketable securities			45,900,000
Current cash, cash equivalents and marketable securities	14%
Accumulated deficit			(1,864,714,000)		$ (1,819,821,000)
Maximum [Member]
Accounting Policy [Line Items]
Cash, FDIC insured amount			$ 250,000
B. Riley Principal Capital II, LLC [Member] | Common Class A [Member] | Maximum [Member]
Accounting Policy [Line Items]
Newly issued shares, value		$ 100,000,000
Number of shares, percentage		19.99%
Accounts Receivable [Member]
Accounting Policy [Line Items]
Number of customers | Customers			3	1	3
Accounts Receivable [Member] | Customer [Member] | One Customer [Member]
Accounting Policy [Line Items]
Concentration risk percentage			30.90%	90.90%	53.30%
Accounts Receivable [Member] | Customer [Member] | Two Customer [Member]
Accounting Policy [Line Items]
Concentration risk percentage			22%		21.70%
Accounts Receivable [Member] | Customer [Member] | Three Customer [Member]
Accounting Policy [Line Items]
Concentration risk percentage			15.80%		20.80%
Revenue [Member]
Accounting Policy [Line Items]
Number of customers | Customers			0

Revenues - Schedule of Revenue

Revenues - Schedule of Revenue Disaggregated by Type of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Total revenues	$ 0	$ 3,911
Launch Services [Member]
Disaggregation of Revenue [Line Items]
Total revenues	0	3,911
Space Products [Member]
Disaggregation of Revenue [Line Items]
Total revenues	$ 0	$ 0

Revenues - Additional Informati

Revenues - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Revenues [Abstract]
Contract asset	$ 0		$ 0
Contract liabilities	30,000		$ 24,100
Revenue	0	$ 2,300
Other income (expense), net	$ 0	$ 400

Revenues - Additional Informa_2

Revenues - Additional Information (Details 1) $ in Millions	Mar. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 45.5
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 80.6
Expected timing of performance obligation satisfaction, period	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 35.1
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 35.1
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 35.1
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 35.1
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 35.1
Expected timing of performance obligation satisfaction, period	1 year

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Business Combination Segment Allocation [Line Items]
Decrease in fair value of contingent consideration liability	$ 2,765	$ (15,500)
Cash and Cash Equivalents, Period Increase (Decrease)	(16,839)	(163,486)
Loss (Gain) on change in fair value of contingent consideration	(2,765)	15,500
General and administrative expenses	15,682	$ 20,986
Additional paid in capital	$ 1,907,982		$ 1,902,213
Common Class A [Member]
Business Combination Segment Allocation [Line Items]
Common stock, shares issued	215,286,444		213,697,468
Common stock, shares outstanding	215,286,444		213,697,468
Common stock, par value	$ 0.0001		$ 0.0001
Common Class B [Member]
Business Combination Segment Allocation [Line Items]
Common stock, shares issued	55,539,188		55,539,188
Common stock, shares outstanding	55,539,188		55,539,188
Common stock, par value	$ 0.0001		$ 0.0001

Supplemental Financial Inform_3

Supplemental Financial Information - Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Supplemental Financial Information Abstract
Raw materials	$ 3,631	$ 5,068
Work in progress	3,294	1,520
Finished goods	0	0
Inventories, net	$ 6,925	$ 6,588

Supplemental Financial Inform_4

Supplemental Financial Information - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Property Plant And Equipment [Line Items]
Depreciation	$ 778	$ 1,960
Inventory write-downs	0	5,500
Impairment charges	$ 0	$ 0

Supplemental Financial Inform_5

Supplemental Financial Information - Schedule of Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Prepaid Expense and Other Assets, Current [Abstract]
Deposits	$ 5,009	$ 379
Prepaid license and other prepaid expenses	2,608	3,589
Employee Retention Credit - Payroll Tax	2,101	4,283
Other current assets	2,719	2,799
Prepaid and other current assets	$ 12,437	$ 11,050

Supplemental Financial Inform_6

Supplemental Financial Information - Schedule of Major Classes of Property Plant and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Property Plant And Equipment [Line Items]
Total property, plant and equipment	$ 48,155	$ 45,216
Less: accumulated depreciation	(21,723)	(20,945)
Property, plant and equipment, net	26,432	24,271
Construction in Progress [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	7,287	8,309
Computer and Software [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	2,769	2,810
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	11,645	10,390
Research Equipment [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	8,932	9,042
Production Equipment [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	17,022	14,100
Furniture and Fixtures [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	$ 500	$ 565

Supplemental Financial Inform_7

Supplemental Financial Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Other Liabilities, Current [Abstract]
Employee compensation and benefits	$ 3,571	$ 5,861
Contract liabilities, current portion	29,334	24,137
Construction in progress related accruals	66	2,692
Accrued expenses	4,991	5,179
Accrued inventory purchases	3,886	0
Other (miscellaneous)	913	4,174
Accrued expenses and other current liabilities	$ 42,761	$ 42,043

Supplemental Financial Inform_8

Supplemental Financial Information - Schedule of Other Non Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Accrued Liabilities and Other Liabilities [Abstract]
Contract liabilities, net of current portion	$ 691	$ 0
Other (miscellaneous)	1,905	1,796
Other non-current liabilities	$ 2,596	$ 1,796

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Sep. 30, 2022	Mar. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Asset Impairment Charges	$ 0		$ 0
Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Asset Impairment Charges	$ 0	$ 4,800,000

Intangible Assets - Summary of

Intangible Assets - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross	$ 12,415	$ 12,415
Intangible assets accumulated amortization	(4,956)	(4,389)
Intangible assets subject to amortization, accumulated amortization	(4,956)	4,389
Total intangible assets	7,459	8,026
Total intangible assets, Carrying amount	14,521	14,521
Total intangible assets	9,565	10,132
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Carrying amount	2,106	2,106
Infinite lived intangible assets accumulated amortization	0	0
Total intangible assets	2,106	2,106
Developed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross	9,909	9,909
Intangible assets subject to amortization, accumulated amortization	(3,299)	2,910
Total intangible assets	6,610	6,999
Customer Contracts And Related Relationship [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross	2,383	2,383
Intangible assets subject to amortization, accumulated amortization	(1,544)	1,376
Total intangible assets	839	1,007
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross	123	123
Intangible assets subject to amortization, accumulated amortization	(113)	103
Total intangible assets	$ 10	$ 20

Intangible Assets - Expected Fu

Intangible Assets - Expected Future Amortization Expense Related to Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (remainder)	$ 1,680
2024	1,891
2025	1,555
2026	1,555
2027	778
Total intangible assets	$ 7,459	$ 8,026

Warrant Liabilities - Additiona

Warrant Liabilities - Additional Information (Details) - shares	Mar. 31, 2023	Dec. 31, 2022
Common Class A [Member]
Class of Warrant or Right [Line Items]
Common stock, shares issued	215,286,444	213,697,468

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Aug. 16, 2022
Income Tax Disclosure [Abstract]
Income tax (benefit) expense	$ 0	$ 0
Percent of minimum tax on book income			15%
Percent of excise tax on net stock repurchases			1%

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of fair value hierarchy (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets:
Total financial assets	$ 47,959	$ 91,082
Liabilities:
Total financial liabilities	31,135	33,900
Contingent Consideration [Member]
Liabilities:
Total financial liabilities	$ 31,135	$ 33,900
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Liabilities	Liabilities
Level 1 [Member]
Assets:
Total financial assets	$ 13,874	$ 36,622
Liabilities:
Total financial liabilities	0	0
Level 1 [Member] | Contingent Consideration [Member]
Liabilities:
Total financial liabilities	0	0
Level 2 [Member]
Assets:
Total financial assets	34,085	54,460
Liabilities:
Total financial liabilities	0	0
Level 2 [Member] | Contingent Consideration [Member]
Liabilities:
Total financial liabilities	0	0
Level 3 [Member]
Assets:
Total financial assets	0	0
Liabilities:
Total financial liabilities	31,135	33,900
Level 3 [Member] | Contingent Consideration [Member]
Liabilities:
Total financial liabilities	31,135	33,900
Money market account
Assets:
Total financial assets	2,015	21,909
Money market account | Level 1 [Member]
Assets:
Total financial assets	2,015	21,909
Money market account | Level 2 [Member]
Assets:
Total financial assets	0	0
Money market account | Level 3 [Member]
Assets:
Total financial assets	0	0
US Treasury securities
Assets:
Total financial assets	11,859	14,713
US Treasury securities | Level 1 [Member]
Assets:
Total financial assets	11,859	14,713
US Treasury securities | Level 2 [Member]
Assets:
Total financial assets	0	0
US Treasury securities | Level 3 [Member]
Assets:
Total financial assets	0	0
Corporate debt securities
Assets:
Total financial assets	6,962	16,915
Corporate debt securities | Level 1 [Member]
Assets:
Total financial assets	0	0
Corporate debt securities | Level 2 [Member]
Assets:
Total financial assets	6,962	16,915
Corporate debt securities | Level 3 [Member]
Assets:
Total financial assets	0	0
Commercial paper
Assets:
Total financial assets	27,123	34,698
Commercial paper | Level 1 [Member]
Assets:
Total financial assets	0	0
Commercial paper | Level 2 [Member]
Assets:
Total financial assets	27,123	34,698
Commercial paper | Level 3 [Member]
Assets:
Total financial assets	$ 0	0
Asset backed securities
Assets:
Total financial assets		$ 2,847
Derivative Liability, Statement of Financial Position [Extensible Enumeration]		Assets
Asset backed securities | Level 1 [Member]
Assets:
Total financial assets		$ 0
Asset backed securities | Level 2 [Member]
Assets:
Total financial assets		2,847
Asset backed securities | Level 3 [Member]
Assets:
Total financial assets		$ 0

Fair Value Measurements - Summa

Fair Value Measurements - Summary of the Changes In Fair Value of the Company Financial Instruments (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Fair value as of December 31, 2022	$ 33,900
Gain on change in fair value of contingent consideration	(2,765)
Fair value as of March 31, 2023	$ 31,135

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Range of Inputs To Determine The fair Value of Contingent Consideration (Details)	Mar. 31, 2023	Dec. 31, 2022
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	3.81	4.14
Expected revenue volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	19	19
Revenue discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	10	10
Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	8	7.50

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	$ 45,985	$ 69,283
Gross Unrealized Loss	(41)	(110)
Fair Value	45,944	69,173
US Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	11,876	14,763
Gross Unrealized Loss	(17)	(50)
Fair Value	11,859	14,713
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	6,986	16,972
Gross Unrealized Loss	(24)	(57)
Fair Value	6,962	16,915
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	27,123	34,698
Gross Unrealized Loss	0	0
Fair Value	$ 27,123	34,698
Asset backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost		2,850
Gross Unrealized Loss		(3)
Fair Value		$ 2,847

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of Breakdown of the Available-for-Sale Marketable Securities in an Unrealized Loss Position (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
US Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Less than 12 months	$ 11,859	$ 14,713
Fair Value, Total	11,859	14,713
Gross Unrealized Loss, Less than 12 months	17	50
Gross Unrealized Loss, Total	17	50
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Less than 12 months	6,962	16,915
Fair Value, Total	6,962	16,915
Gross Unrealized Loss, Less than 12 months	24	57
Gross Unrealized Loss, Total	24	57
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Less than 12 months	27,123	34,698
Fair Value, Total	27,123	34,698
Gross Unrealized Loss, Less than 12 months	0	0
Gross Unrealized Loss, Total	$ 0	0
Asset backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Less than 12 months		2,847
Fair Value, Total		2,847
Gross Unrealized Loss, Less than 12 months		3
Gross Unrealized Loss, Total		$ 3

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) $ in Millions	3 Months Ended
	Sep. 30, 2022 USD ($)
Fair Value Disclosures [Abstract]
Realized loss	$ 0.1

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Gains or Losses on Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Amortized Cost, Due in 1 year or less	$ 45,985	$ 69,283
Fair Value, Due in 1 year or less	$ 45,944	$ 69,173

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 14, 2023	May 20, 2022	Apr. 27, 2022
Retention costs payable			$ 1.5	$ 20
Common stock, shares authorized	466,000,000
Outstanding purchase commitments	$ 28.4
Maximum [Member]
Common stock, shares authorized		465,000,000
Minimum [Member]
Common stock, shares authorized		220,000,000

Convertible Preferred Stock - A

Convertible Preferred Stock - Additional Information (Details) - shares	Mar. 31, 2023	Dec. 31, 2022
Preferred stock, shares outstanding	0
Convertible Preferred Stock [Member]
Preferred stock, shares outstanding	0	0

Convertible Preferred Stock - S

Convertible Preferred Stock - Schedule of Three Classes of Convertible Preferred Stock Before Combination (Details)	Mar. 31, 2023 shares
Preferred stock, shares outstanding	0

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended
	Aug. 31, 2022	Aug. 02, 2022	Mar. 31, 2023	Dec. 31, 2022
Common stock, shares authorized			466,000,000
Preferred stock, shares outstanding			0
B. Riley Principal Capital II, LLC [Member]
Sale of stock, description			Sales of the Shares pursuant to the Purchase Agreement, and the timing of any sales, are solely at the option of the Company beginning on September 13, 2022.
Common Class A [Member]
Common stock, shares authorized			400,000,000	400,000,000
Common stock, par value			$ 0.0001	$ 0.0001
Common stock, shares issued			215,286,444	213,697,468
Percentage of Weighted Average Price of Common Stock	97%
Common Class A [Member] | B. Riley Principal Capital II, LLC [Member]
Outstanding shares, percentage	4.99%
Common Class A [Member] | B. Riley Principal Capital II, LLC [Member] | Purchase Agreement And Registration Rights Agreement [Member]
Newly issued shares, value		$ 100
Common Class B [Member]
Common stock, shares authorized			65,000,000	65,000,000
Common stock, par value			$ 0.0001	$ 0.0001
Common stock, shares issued			55,539,188	55,539,188
Convertible Preferred Stock [Member]
Preferred stock, shares outstanding			0	0
Preference shares authorized			1,000,000	1,000,000
Preference shares, par value (in Dollars per share)			$ 0.0001	$ 0.0001
Preferred Stock [Member]
Preference shares authorized			1,000,000
Preference shares, par value (in Dollars per share)			$ 0.0001
Class A and Class B Common Stock [Member] | B. Riley Principal Capital II, LLC [Member] | Purchase Agreement And Registration Rights Agreement [Member]
Newly issued shares		53,059,650
Number of shares, percentage		19.99%

Stock-based Compensation - Addi

Stock-based Compensation - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Unvested aggregate intrinsic value	$ 2,184
Stock-Based Awards [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Weighted average period expected to be recognized	3 years
Unrecognized Stock Based Compensation Expense	$ 56,400
Restricted Stock Units (RSUs) [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total fair value as of the respective vesting dates of restricted stock units vested	800
Unvested aggregate intrinsic value	6,200
PSUs [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Compensation cost	100	$ 1,000
2021 Employee Stock Purchase Plan [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Remain available for issuance	$ 9,100
Discount on Shares Purchased			15%
Shares Issued	0.8
Unrecognized Stock Based Compensation Expense	$ 400
Cost Over Weighted Average Period	9 months 7 days

Stock-based Compensation - Summ

Stock-based Compensation - Summary of Share-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ 5,328	$ 17,041
Cost of revenues [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	0	241
Research and Development [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	2,359	6,736
Sales and Marketing [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	380	1,580
General and Administrative [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ 2,589	$ 8,484

Stock-based Compensation - Su_2

Stock-based Compensation - Summary of stock option activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]
Options outstanding Beginning balance, Shares	16,248,601	20,326,384	20,326,384
Options outstanding, Granted	10,535,783	1,142,027
Options outstanding, Exercised	(180,923)	(176,774)
Options outstanding, Forfeited	(878,620)	(24,661)
Options outstanding, Expired	(23,330)	(1,465)
Options Outstanding, Ending balance, Shares	25,701,511	21,265,511	16,248,601	20,326,384
Unvested, Ending balance	22,171,996
Exercisable, Ending balance	3,529,515
Options outstanding Beginning balance, Shares	$ 7.11	$ 7.52	$ 7.52
Options outstanding, Granted	0.55	5.21
Options Outstanding, Exercised	0.46	0.45
Options outstanding, Forfeited	0.65	2.93
Options outstanding, Expired	1.65	6.75
Options Outstanding, Ending balance, Shares	4.69	$ 7.46	$ 7.11	$ 7.52
Weighted- Average Exercise Price - Unvested	4.94
Exercisable - March 31, 2023	$ 3.14
Weighted average remaining term, outstanding	8 years 9 months 18 days	9 years 2 months 12 days	8 years 4 months 24 days	9 years 4 months 24 days
Weighted average remaining term, exercised	4 months 24 days	4 years 4 months 24 days
Weighted Average Remaining Term Granted	1 year 6 months	9 years 9 months 18 days
Weighted- Average Remaining Term Unvested	9 years 2 months 12 days
Weighted Average Remaining Term, Exercisable	7 years 6 months
Outstanding aggregate intrinsic value, Beginning balance	$ 9,630	$ 22,782,654	$ 22,782,654
Aggregate Intrinsic value exercised		783,216
Outstanding aggregate intrinsic value, Ending balance	10,124	$ 11,290,701	$ 9,630	$ 22,782,654
Unvested aggregate intrinsic value	2,184
Exercisable March 31, 2023	$ 7,940

Stock-based Compensation - Su_3

Stock-based Compensation - Summary of fair value of options granted (Details) - Time Based Options - $ / shares		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected terms (years)	[1]	6 years 8 months 15 days	5 years 9 months 21 days
Expected volatility	[2]	98.20%	68.90%
Risk-free interest rate	[3]	3.46%	1.70%
Expected dividend rate	[4]	0%	0%
Grant-date fair value			$ 3.20
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant-date fair value		$ 0.42
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant-date fair value		$ 0.56
[1] The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. Expected volatility, or the standard deviation of annualized returns, was calculated based on comparable companies’ reported volatilities. Risk-free interest was obtained from U.S. treasury notes for the expected terms noted as of the valuation date The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future

Stock-based Compensation - Su_4

Stock-based Compensation - Summary of restricted stock units (Details) - RSUs [Member] - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning balance	16,121,844	10,678,818
Number of RSUs Outstanding Granted	990,959	3,937,226
Number of RSUs Outstanding, Vested	(627,185)	(828,680)
Number of RSUs Outstanding, Forfeited	(1,944,250)	(328,562)
Outstanding, ending balance	14,541,368	13,458,802
Weighted- Average Grant Date Fair Value Per Share, Beginning balance	$ 3.35	$ 9.20
Grant-date fair value	0.52	4.25
Weighted Average Grant Date Fair Value Per Share, Vested	6.51	8.64
Weighted Average Grant Date Fair Value Per Share, Forfeited	3.71	9.23
Weighted- Average Grant Date Fair Value Per Share, Ending balance	$ 2.97	$ 7.78

Loss per Share - Schedule of Co

Loss per Share - Schedule of Computation of Basic and Diluted Loss (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Common Class A [Member]
Net loss attributed to common stockholders	$ (35,667)	$ (67,657)
Basic weighted average common shares outstanding	214,706,779	208,112,630
Dilutive weighted average common shares outstanding	214,706,779	208,112,630
Income (Loss) from Continuing Operations, Per Basic Share	$ (0.17)	$ (0.33)
Income (Loss) from Continuing Operations, Per Diluted Share	$ (0.17)	$ (0.33)
Common Class B [Member]
Net loss attributed to common stockholders	$ (9,226)	$ (18,056)
Basic weighted average common shares outstanding	55,539,188	55,539,188
Dilutive weighted average common shares outstanding	55,539,188	55,539,188
Income (Loss) from Continuing Operations, Per Basic Share	$ (0.17)	$ (0.33)
Income (Loss) from Continuing Operations, Per Diluted Share	$ (0.17)	$ (0.33)

Loss per Share - Additional Inf

Loss per Share - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Preferred dividends declared	$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	0

Loss per Share - Schedule of _2

Loss per Share - Schedule of Computation of diluted Shares Outstanding (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	0	0
Common Class A [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	30,497,564	21,608,652
Common Class A [Member] | RSUs [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	14,533,186	13,359,326
Common Class A [Member] | Stock Options [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	15,939,378	8,249,326
Common Class A [Member] | Warrant [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	25,000	0

Segment Information - Schedule

Segment Information - Schedule of Segment Reporting Information by Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Total revenues	$ 0	$ 3,911
Total cost of revenues	0	11,014
Total gross profit (loss)	0	(7,103)
Launch Services [Member]
Segment Reporting Information [Line Items]
Total revenues	0	3,911
Total cost of revenues	0	11,014
Total gross profit (loss)	0	(7,103)
Space Products [Member]
Segment Reporting Information [Line Items]
Total revenues	0	0
Total cost of revenues	0	0
Total gross profit (loss)	$ 0	$ 0

Segment Information - Summary o

Segment Information - Summary of Reconciles Segment Gross Profit to Loss Before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting [Abstract]
Gross profit (loss)	$ 0	$ (7,103)
Research and development	31,082	37,927
Selling and marketing	2,484	4,764
General and administrative	15,682	20,986
Loss (Gain) on change in fair value of contingent consideration	(2,765)	15,500
Interest (income) expense, net	(1,330)	(174)
Other expense (income), net	(260)	(393)
Loss before taxes	$ (44,893)	$ (85,713)

Segment Information - Additiona

Segment Information - Additional Information (Details) - Segment	3 Months Ended	9 Months Ended
	Mar. 31, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Number of Operating and Reportable Segments	1	2

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Award granted	10,535,783	1,142,027
Stock-based compensation	$ 5,328	$ 17,041
RSUs [Member]
Defined Benefit Plan Disclosure [Line Items]
Value of RSUs	$ 800